| Authors: |
Conti RM; Boston University, Boston, Massachusetts, USA rconti@bu.edu., McCue S; Mayo Clinic Research Rochester, Rochester, Minnesota, USA., Dockter T; Mayo Clinic Research Rochester, Rochester, Minnesota, USA., Gunn H; Mayo Clinic Research Rochester, Rochester, Minnesota, USA., Dusetzina S; Health Policy, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Bennett A; Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Rapkin BD; Epiemiology and Population Health, Albert Einsein College of Medicine, Bronx, New York, UK., Gracia G; University of Illinois Chicago, Chicago, Illinois, USA., Jazowski SA; Vanderbilt University School of Medicine, Nashville, Tennessee, USA., Behrens R; Iowa Wide Oncology Research Coalition, Des Moines, IA, Des Moines, Iowa, USA., Richardson PG; Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Chow S; Alliance Protocol Operations Office, University of Chicago, Chicago, IL, Chicago, Illinois, USA., Subbiah N; Cancer Control Program, Alliance NCTN Foundation, Chicago, Illinois, Chicago, Illinois, USA., Neuman HB; University of Wisconsin, Madison, Wisconsin, USA., Chang GJ; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; The University of Texas MD Anderson Cancer Center., Weiss E; Leukemia and Lymphoma Society, Rye Brook, New York, USA. |
